Stenotrophomonas Bacteremia Antibiotic Susceptibility and Prognostic Determinants: Mayo Clinic 10-Year Experience

Risk factors for death from Stenotrophomonas maltophilia bacteremia

(2018) Kayo Osawa et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years

(2018) Consuelo Velázquez-Acosta et al.   SUPPORTIVE CARE IN CANCER

1042. Stenotrophomans maltophilia Bacteremia, A 10-Year Tertiary Center Experience

(2018) Ahmed Hamdi et al.   Open Forum Infectious Diseases

Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series

(2017) Hirotaka Ebara et al.   INTERNAL MEDICINE

Clinical outcomes using minocycline for Stenotrophomonas maltophilia infections

(2016) Shauna Jacobson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment ofStenotrophomonas maltophiliainfections

(2016) Elizabeth Hand et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparisons between patients with trimethoprim–sulfamethoxazole-susceptible and trimethoprim–sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study

(2016) Ching-Hsun Wang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia

(2016) Yong Duk Jeon et al.   MEDICINE

Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study

(2015) Kosuke Sumida et al.   PLoS One

Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options

(2015) Ya-Ting Chang et al.   Frontiers in Microbiology

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

(2012) J. S. Brooke   CLINICAL MICROBIOLOGY REVIEWS